— Know what they know.
Not Investment Advice

SKVI OTC

Skinvisible, Inc.
1W: +0.6% 1M: +12.3% 3M: -4.9% YTD: -12.4% 1Y: -6.8% 3Y: +102.1% 5Y: +134.9%
$0.20
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 49 · $1.1M mcap · 5M float · 0.015% daily turnover · Short 58% of daily vol

Cash Flow Trends

Operating Cash Flow
-$70K +9.5% ▲
Capital Expenditures
$9K +1.2% ▲
5Y CAGR: -18.8%
Free Cash Flow
-$79K +8.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$9K +111.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$1M-$1M-$1M-$2M-$566K
Depreciation & Amort.$32K$18K$19K$19K$20K
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$797K$736K$767K$981K$1M
Other Non-Cash Items$664K$693K$484K$1M-$574K
Operating Cash Flow$46K$375K$45K-$77K-$70K
— Investing Activities —
Capital Expenditures-$17K-$21K-$3K-$9K-$9K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$17K-$21K-$3K$0$0
Investing Cash Flow-$17K-$21K-$3K-$9K-$9K
— Financing Activities —
Net Debt Issuance$6K-$118K$0$6K$22K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0-$205K-$27K$0$0
Financing Cash Flow$6K-$324K-$27K$6K$88K
Net Change in Cash$35K$30K$15K-$80K$9K
Cash End of Period$36K$66K$81K$888$10K
Free Cash Flow$29K$354K$43K-$86K-$79K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms